SELPERCATINIB for Lung neoplasm malignant: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 158 adverse event reports in the FDA FAERS database where SELPERCATINIB was used for Lung neoplasm malignant.
Most Reported Side Effects for SELPERCATINIB
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Malignant neoplasm progression | 106 | 9.8% | 31 | 32 |
| Death | 90 | 8.3% | 88 | 1 |
| Hypertension | 58 | 5.4% | 1 | 18 |
| Hypersensitivity | 55 | 5.1% | 4 | 34 |
| Diarrhoea | 54 | 5.0% | 10 | 19 |
| Fatigue | 51 | 4.7% | 2 | 16 |
| Rash | 49 | 4.5% | 2 | 17 |
| Hepatic function abnormal | 42 | 3.9% | 3 | 21 |
| Alanine aminotransferase increased | 38 | 3.5% | 4 | 19 |
| Pyrexia | 38 | 3.5% | 1 | 18 |
| Aspartate aminotransferase increased | 37 | 3.4% | 4 | 17 |
| Ascites | 33 | 3.0% | 3 | 7 |
| Dry mouth | 32 | 3.0% | 5 | 10 |
| Electrocardiogram qt prolonged | 32 | 3.0% | 1 | 18 |
| Thrombocytopenia | 31 | 2.9% | 5 | 16 |
Other Indications for SELPERCATINIB
Non-small cell lung cancer (231)
Product used for unknown indication (214)
Medullary thyroid cancer (116)
Thyroid cancer (59)
Lung adenocarcinoma (50)
Non-small cell lung cancer stage iv (23)
Lung adenocarcinoma stage iv (20)
Lung carcinoma cell type unspecified stage 0 (19)
Non-small cell lung cancer metastatic (18)
Neoplasm malignant (15)
Other Drugs Used for Lung neoplasm malignant
ERLOTINIB (9,207)
OSIMERTINIB (4,754)
NIVOLUMAB (4,197)
PEMBROLIZUMAB (3,575)
CARBOPLATIN (3,487)
ALECTINIB (2,932)
PEMETREXED (2,422)
CRIZOTINIB (1,949)
BEVACIZUMAB (1,810)
PACLITAXEL (1,747)